Dr. Zeitels said that in his preliminary study, what we are seeing is that the voice data is the best we ever had, especially for those patients with bilateral disease. Objective voice measures revealed overall improvements in the postsurgical group. These results substantiated stroboscopic findings of enhanced mucosal wave function and vocal fold vibration.
Explore This Issue
June 2008We created a hybrid technique employing microsurgically directed nonionizing radiation. Incremental treatment of the glottis is much like treating sun-damaged skin in that you are trying to optimize the form and function. You are essentially reducing mid-sized tumors into smaller ones or complete involution and going back after six weeks to confirm resolution or treat residual limited disease. As necessary with bilateral disease in the anterior commissure, we intentionally leave a little tumor anteriorly on one vocal fold to avoid a synechia and web, since we know we are coming back in six weeks to finish the job.
Dr. Zeitels disclosed possible conflicts of interest with Laserscope Inc., Pentax Inc., and Endocraft LLC. His work also received funding from the nonprofit Eugene B. Casey Foundation and the Institute of Laryngology and Voice Restoration. We have not received any financial remuneration from any laser company, he said. We have received lasers.
©2008 The Triological Society
Leave a Reply